Harding Loevner’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-340,083
Closed -$49M 71
2024
Q4
$49M Sell
340,083
-576,059
-63% -$82.6M 0.33% 51
2024
Q3
$136M Buy
916,142
+283,163
+45% +$40.6M 0.79% 45
2024
Q2
$79.8M Sell
632,979
-26,435
-4% -$4.14M 0.44% 56
2024
Q1
$121M Sell
659,414
-56,885
-8% -$10.8M 0.75% 47
2023
Q4
$129M Sell
716,299
-9,109
-1% -$1.42M 0.72% 50
2023
Q3
$115M Buy
+725,408
New +$119M 0.76% 48
2022
Q4
Sell
-135
Closed -$25K 142
2022
Q3
$25K Sell
135
-42
-24% -$8.86K ﹤0.01% 118
2022
Q2
$29K Hold
177
﹤0.01% 112
2022
Q1
$26K Buy
177
+97
+121% +$18.4K ﹤0.01% 114
2021
Q4
$21K Hold
80
﹤0.01% 140
2021
Q3
$23K Hold
80
﹤0.01% 121
2021
Q2
$16K Hold
80
﹤0.01% 143
2021
Q1
$16K Hold
80
﹤0.01% 143
2020
Q4
$15K Hold
80
﹤0.01% 136
2020
Q3
$12K Sell
80
-146
-65% -$20.9K ﹤0.01% 170
2020
Q2
$28K Sell
226
-27
-11% -$3.18K ﹤0.01% 118
2020
Q1
$24K Hold
253
﹤0.01% 120
2019
Q4
$23K Hold
253
﹤0.01% 122
2019
Q3
$19K Buy
+253
New +$22.1K ﹤0.01% 121

Other funds holding RGEN

Harding Loevner's RGEN Position: Q1 2025 in Review

Harding Loevner sold out of Repligen (RGEN) in Q1 2025, closing a stake of 340,083 shares — an estimated $49M sold.

Harding Loevner first reported a position in RGEN in Q3 2019 and held it in 19 quarters. The position peaked at $136M in Q3 2024. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2025.

  • Harding Loevner reported no remaining Repligen position as of Q1 2025 after selling out during the quarter.
  • Harding Loevner sold 340,083 Repligen shares in Q1 2025, an estimated $49M.
  • Harding Loevner first reported a position in Repligen in Q3 2019 and held it in 19 quarters.
  • Harding Loevner's Repligen position peaked at $136M in Q3 2024.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2025.

Based on Harding Loevner's 13F filing for Q1 2025, filed 15 May 2025.